ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,632Medicare Part D Prescriptions Filled, Including Refills

Rank: 124 out of 2094

$1.27M Total Retail Price of All Prescriptions

Rank: 40 out of 2094

345 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

34% of this provider’s 345 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 345 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 7,053 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$109 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
OXYCODONE HCL 1,171 327 S2 1 63
CRESTOR 301 204 2 15
MELOXICAM 270 117 3 49
ZOLPIDEM TARTRATE 249 83 4 14
LEVOTHYROXINE SODIUM 246 186 5 3
OXYCONTIN 196 76 S2 6 98
GLIMEPIRIDE 173 139 7 31
NEXIUM 154 81 8 16
FUROSEMIDE 151 123 9 6
CIPROFLOXACIN HCL 142 85 10 81
ATORVASTATIN CALCIUM 137 131 11 5
AMLODIPINE BESYLATE 135 109 12 2
CILOSTAZOL 124 118 13 204
EVISTA 120 90 14 131
OXYCODONE HCL-ACETAMINOPHEN 119 61 S2 15 119
OMEPRAZOLE 119 83 15 4
METFORMIN HCL 119 82 15 8
MORPHINE SULFATE ER 109 0 S2 18 192
SIMVASTATIN 105 82 19 1
LEVOCETIRIZINE DIHYDROCHLORIDE 105 50 19 169
TRAMADOL HCL 101 77 21 33
ALLOPURINOL 99 84 22 50
METOPROLOL SUCCINATE 97 83 23 9
CARISOPRODOL 94 0 R 24 253
DEXILANT 90 76 25 124
WARFARIN SODIUM 90 73 25 11
DIOVAN 90 76 25 13
TRILIPIX 90 67 25 156
ALENDRONATE SODIUM 89 73 29 30
CLOPIDOGREL 89 84 29 22
BUMETANIDE 81 70 31 236
DIOVAN HCT 81 62 31 28
PLAVIX 80 78 33 38
PROAIR HFA 77 23 34 45
ORPHENADRINE CITRATE 77 23 R 34 450
AZITHROMYCIN 76 37 36 27
FENOFIBRATE 76 59 36 104
CITALOPRAM HBR 70 31 38 47
CYCLOBENZAPRINE HCL 70 0 R 38 115
LEVOFLOXACIN 70 42 38 70
ONGLYZA 67 44 41 134
DIGOXIN 67 55 41 51
ESCITALOPRAM OXALATE 66 43 43 46
TORSEMIDE 65 60 44 118
METOPROLOL TARTRATE 64 55 45 10
LYRICA 61 32 46 85
SYNTHROID 61 46 46 44
QUETIAPINE FUMARATE 60 50 48 71
HYDRALAZINE HCL 60 42 48 89
CELEBREX 58 34 50 74
ALPRAZOLAM 57 29 51 150
BACLOFEN 54 35 52 166
PANTOPRAZOLE SODIUM 54 43 52 37
DONEPEZIL HCL 53 53 54 20
COLCRYS 53 48 54 230
CARVEDILOL 53 37 54 19
VESICARE 51 49 57 152
LISINOPRIL 50 48 58 7
AMOXICILLIN 50 17 58 147
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 15, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.